Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Centre Hospitalier Universitaire De Poitiers has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. The prosecution involves 1 distinct examiner and 1 distinct art unit. This indicates that the company's current patent activity is focused on a single application or a very narrow set of claims within the 1 distinct art unit. The 1 pending office action is the only active matter currently requiring a response.
The busiest examiner for the portfolio is CHEN, STACY BROWN, who is managing 1 busiest examiner pending office action. This 1 busiest examiner pending office action accounts for the total pending office actions for the company. All current interactions with the patent office are therefore concentrated through CHEN, STACY BROWN. For the practitioner, this means the prosecution strategy is entirely dependent on the examination style and requirements of this 1 distinct examiner. Success in this matter will depend on addressing the specific technical concerns raised within the Biotechnology & Pharmaceuticals domain.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CHEN, STACY BROWN | 1 | 66.1% | +40.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18573948 | PROBES BASED ON VOLATILE ORGANIC COMPOUNDS AND USES THEREOF FOR THE DIAGNOSIS AND PROGNOSIS OF PATHOLOGICAL CONDITIONS | CHEN, STACY BROWN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18573948 | PROBES BASED ON VOLATILE ORGANIC COMPOUNDS AND USES THEREOF FOR THE DIAGNOSIS AND PROGNOSIS OF PATHOLOGICAL CONDITIONS | CHEN, STACY BROWN | — |
| Art Unit | Apps |
|---|---|
| 1672 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18573948 | PROBES BASED ON VOLATILE ORGANIC COMPOUNDS AND USES THEREOF FOR THE DIAGNOSIS AND PROGNOSIS OF PATHOLOGICAL CONDITIONS | CHEN, STACY BROWN | 1672 | §101§112 | Non-Final OA | — | Pending | Dec 22, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialCentre Hospitalier Universitaire De Poitiers has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Stacy Brown Chen has the most, with 1 of Centre Hospitalier Universitaire De Poitiers's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
